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Abstract 
The biochemical modulations by fatty acids as a major components of lipids cannot be over-emphasized. The 
apolipoprotein-containing (LDL, VLDL and TG) and nonapolipoprotein-containing (HDL) lipid biomolecules. 
Cod liver oil has since gained acceptance as reliable lipid source compared to other sources of lipids that had 
been reported by researchers to have hypocholesterolemic activities. This study was aimed at comparing quail 
egg yolk hexane extract with cod liver oil. This research was the proceed of the antidyslipidemic activities of 
quail egg yolk hexane extract and the decision to compare with other acceptable fatty acid source. The 
comparism between these samples was evaluated by analytical processes carried out by Gas Chromatography 
coupled with Mass Spectrophotometer (GC-MS) and clinical lipid profile assays-HDL,TChol and TG, VLDL, 
LDL. atherogenic coefficient and index as well as coronary risk index, HDL/LDL-C and some other parameters 
that define dyslipidemia were calculated. Competitive activities were inferred between quail egg yolk hexane 
extract and cod liver oil, however, the cod liver oil had more antidyslipidemic effect than quail egg yolk. The n-
6:n-3 ratio showed a more viable codliver oil than quail egg yolk extract-0.386 and 0.525 respectively.  
Keywords: Fatty acids, LDL,VLDL, Total Cholesterol, HDL, Atherogenicity, Dyslipidemia, Cod liver oil, Quail 
egg yolk lipid 
 
Abbreviations: High Density Lipoprotein (HDL), Low Density Lipoprotein (LDL), Total Cholesterol (TChol), 
Very Low Density Lipoprotein (VLDL), Triglyceride (TG), Omega 6 (n-6), Omega 3 (n-3), Cholesterol (C), 
Polyunsaturated Fatty Acid (PUFA), Cardiovascular Disease (CVD), Cholesteryl Ester Transfer Protein (CETP), 
Lipoprotein Lipase (LPL), LDL Receptor (LDLR), Microsomal Triglyceride Transfer Protein (MTP) 
 
INTRODUCTION 
Fatty acids are the building blocks from which lipids are made. It has been estimated that less than 8% of alpha 
linoleic acid (ALA) is metabolised to eicosapentaenoic (EPA), and the capacity for the body to synthesize 
docosahexaenoic acid (DHA) appears to be particularly limited. It is estimated that only between 0.02% and 4% 
of ALA is metabolised to DHA [1-3], with women having a greater capacity for DHA synthesis than men [4]. 
Feedback inhibition of enzymes involved in n-3 and n-6 fatty acid synthesis occurs; for example, if the amount 
of DHA in the diet increases, there is reduced metabolism of ALA to EPA. Furthermore, n-3 and n-6 fatty acids 
compete for the enzymes involved in fatty acid elongation and desaturation, with certain enzymes having greater 
affinity for n-3 fatty acids and others having greater affinity for the n-6 series [5]. 
Essential components of lipids which include n-3 PUFAs have been established to possess antioxidant 
properties which have been shown to have lipid peroxidation inhibition activities. High cholesterol in the liver, a 
condition known as fatty liver or steatosis, has been attributed to hyperlipidemia, which as a result of electrically 
unpaired radical form of cholesteryl ester is able to activate degeneration of biomolecular components of these 
organs leading to inflammation and oxidative stress as a whole.  
Lipid profile consists of a group of biochemical testes often used in predicting, diagnosing and treating 
lipid related disorders for example, atherosclerosis. Prospective epidemiologic studies have shown that blood 
levels of low-density lipoprotein cholesterol (LDL-C) significantly predict incident atherosclerotic 
cardiovascular disease (CVD), and LDL-C-lowering therapy has been repeatedly demonstrated in many 
populations to reduce CVD risk [6]. This has led to the formulation of risk prediction algorithms for 
identification of high-risk individuals and specific LDL-C goals to be achieved with lifestyle and 
pharmacological interventions [7]. Generally, hyperlipidemias are of interest to the physician in the context of 
risk factors for Ischemic heart disease (IHD) and peripheral vascular disease. The first step in diagnosis of hyper-
and hypolipoproteinaemias is to define the lipoprotein pattern by chemical analysis of the plasma lipid and 
lipoproteins [8]. Accumulated evidences relating the concentrations of lipids (TChol and TG) and their 
associated blood transporting lipoproteins (HDL-C, LDL-C,VLDL-C) with the occurrence of atherosclerosis in 
general and Cardiovascular diseases (CVD) in particular [9]. 
Several deaths associated with tumor and disorders of the metabolic organ (liver) and organ responsible 
for blood circulation (heart) have been attributed to dyslipidemia. Atherogenic dyslipidemia is a condition 
induced genetically or via diet. The basis for genetics and atherogenic dyslipidemia is that the atherogenic 
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lipoprotein phenotype has numerous genes that influence LDL concentration, these genes include, CETP genes, 
LDLR genes, LPL, MTP and the apolipoprotein genes-APO5,APOB,APOC3 and APOE [6]. Natural alterations 
of these genes leads to dyslipidemia in the organ system irrespective of the cell involved. The perspective of diet 
related dyslipidemia is in line with hypercholesterolemic or high fat diets, which can increase apolipoprotein 
containing molecules (LDL, TG and VLDL) in the circulatory and organ systems.   
Many individuals with normal LDL-C levels nevertheless develop CVD [10], particularly in older age 
groups [6]. Recurrent dyslipidemic diseases have prompted researchers to proffering solutions that will attenuate 
dyslipidemic conditions and thus sustaining better living. The comparative attenuation of dyslipidemia by cod 
liver oil and quail egg yolk lipid extract are evaluated but not cognitive study, using the blood, liver and heart as 
subject of study. 
 
MATERIALS AND METHODS 
Reagents and Chemicals 
Reagents and Chemicals used in this experiment were obtained from different sources such as British Drug 
House (BDH) and were all of good analytical grades and analytical kits were purchased from local distributors of 
Randox Laboratories Limited. All the solutions, buffers and reagents were prepared using glass distilled water. 
Cod liver oil used in this experiment as standard omega-3 supplement (reference drug) was obtained from 
Martadol pharmaceutical shop, Akure, Ondo State. Nigeria and was NAFDAC registered. 
Lipid Extraction 
Lipid from the Coturnix japonica egg yolk was extracted using AOAC (1990) with slight modification, methods 
for lipid extraction and methylation. The yolk sample (up to 50g) is dissolved in chloroform (100ml) in a test 
tube fitted with a condenser, and 1% sulfuric acid in methanol (200ml) was added, before the mixture was 
refluxed for 2 hours (or alternatively the mixture could be left overnight in a stoppered tube at 50°C). Water 
(50ml) containing sodium chloride (5%) is added and the required esters were extracted with hexane (2 x 15ml), 
using Pasteur pipettes to separate the layers. The hexane layer was washed with water (40ml) containing 
potassium bicarbonate (2%) and dried over anhydrous sodium sulfate. The solution was filtered to remove the 
drying agent, and the solvent was removed under reduced pressure in a rotary film evaporator. The extract was 
then stored in an air -tight container in a desiccator at 4oC until when needed. The quail egg yolk lipid extract 
and cod liver oil were profiled for the fatty acids present using GC-MS equipments.  
Gas Chromatography and Mass Spectrophotometry 
The content was concentrated to 1ml for gas chromatography analysis and 1µl was injected into the injection 
port of GC. The GC equipment used was HP 6890 powered with HP chemstation Rev. A09.01 (1206) software. 
The split ratio was 20:1, the carrier gas was nitrogen at inlet temperature of 2500C with a column type of HP 
INNOWax and column dimensions of 30m x 0.25mm x 0.25µm. the oven program parameters include initial 
temperature at 600C, first ramping at 120C/minutes for 20minutes, maintain for 2minutes and second ramping at 
150C/min for 3minutes, maintained for 8minutes. The detector used was FID at 3200C at hydrogen pressure 
22psi and compressed air of 35psi. 
Experimental Design 
Male albino rats were used according to the standard guidelines of the Care and Use of Experimental Animal 
Resources. The rats were housed 5 per cage under constant environmental conditions (20–24 °C; 12 h light/dark 
cycle), and were given ad libitum access to standard pelleted food and water. 15 male albino rats weighing 200 ± 
10 g obtained from standard animal house, were used to access the ability of the quail egg yolk lipid extract as 
anti-dyslipidemic agent with comparison with Cod liver oil for a duration of 4 weeks. 
Group 1: normal chow ad libitum and served as control. 
Group 2: quail egg yolk lipid (630µl/kg body weight). 
Group 3: cod liver oil (630µl/kg body weight). 
Sample Preparation 
The rats were sacrificed by cervical dislocation. Blood samples were collected by cardiac punctures into plain 
bottles. Serum was prepared by aspiration of the clear yellowish liquid after clotting and centrifuged for 10 
minutes at 3000g in a bench centrifuge. The clear supernatant was used for the estimation of serum lipids. The 
animals were quickly dissected and the heart and liver were removed and rinsed with ice cold 1.15% potassium 
chloride. The tissues were then homogenized in ice-cold 0.1M phosphate buffer solution using a Teflon 
homogenizer, and centrifuged for 10 minutes at 3000g in a bench centrifuge to collect the aliquot for 
biochemical evaluations. 
A -Lipid Profile 
Enzymaticaly with commercial test kits from Randox Company, the following fractions of lipids were assayed: 
-Total cholesterol (TCh) [11]. 
-HDL-Cholesterol (HDL-C [12]. 
-Triglycerides (TG) [13]. 
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-Low Density Lipoprotein cholesterol (LDL-C) and Very Low Density Lipoprotein (VLDL-C) was calculated 
using the Friedwald equation [14], as follow: LDL-C = TCh - HDL-C - TG / 5.0 
VLDL = TG / 5.0 
B-The atherogenic indices was calculated as follow: 
-Coronary Risk Index (CRI) = TCh / HDL-C [15]. 
-Atherogenic Coefficient (AC) = (TCh – HDL-C)/ HDL-C [16]. 
-Atherogenic Index of Plasma (AIP) = log (TG / HDL-C) [17].  
Statistical analysis 
Data presented were the means ± and standard deviations; student-t-test was used to compare the significance of 
the difference in the mean values of any two groups. (P≤0.05) was considered statistically significant. 
 
RESULTS  
Table 1: Lipid modulation effect on the atherogenic dyslipidemia 
 Atherogenic 
coefficient 
Coronary risk 
index 
Atherogenic 
index 
HDL-
C/LDL-C 
TAG/HDL-C 
Quail egg yolk 
oil 
2.308±0.217 3.308±0.261 0.922±0.111 1.571±0.111 8.361±1.012 
Cod liver 2.0038±0.011 3.0038±0.171 0.931±0.221 3.373±0.212 8.537±0.926 
Control 4.607±0.225 5.607±0.321 1.309±0.177 1.884±0.262 20.380±1.221 
Values are expressed in mean ± standard deviation. N=5  
 
 
Figure 1: Lipid profile modulation by quail egg yolk hexane extract and cod liver oil in liver, heart and blood. 
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Figure 2: GC-MS lipid profiles of quail egg yolk hexane extract and cod liver oil. 
 
Table 2: Summary of lipid profiles of extract 
 Quail egg yolk Cod liver oil 
n-6 PUFAs 8.93 14.15 
n-3 PUFAs 17.01 36.66 
n-6:n-3 0.524985 0.385979 
 
DISCUSSIONS  
The roles of PUFAs become more important as they are not synthesized in human organism and have to be 
delivered with food [18]. The GC-MS result (Fig. 2) of the samples revealed saturated and unsaturated fatty 
acids presence in the samples. The sum of the amount of omega-3 fatty acids per 100g of samples are 17.01 and 
36.66 for quail egg yolk hexane extracts and cod liver oil respectively. The ratio of n-6:n-3 are 0.525 and 0.386 
approximately for quail egg yolk hexane extracts and cod liver oil respectively. These results justify the basis for 
the higher antiadyslipidemic activities of the cod liver oil over quail egg yolk hexane extracts.  
The result (Fig. 2) revealed stearic acid of 10.04g and 8.72g per 100g of quail egg yolk lipid and cod 
liver oil samples respectively. Stearic or octadecanoic acid, classified as saturated fatty acid (SFA) had been 
shown to have recommendable effects on blood total and low density lipoprotein (LDL) cholesterol levels [19]. 
The concentration of stearic acid is considerably high to enhance stimulation of pericardial muscles as a result of 
the TChol and LDL-C reduction (hypocholesterolemic activity), thus depleting atherogenicity that could result 
from dyslipidemia. The effect of stearic acid is not peculiar with attenuating atherogenic dyslipidemia alone but 
could be responsible for attenuating dyslipidemia in other organs of the system including liver. Palmitoleic acid 
is a monounsaturated fatty acid resembling saturated fatty acids in its ability to lower LDL-C [20,21].     
The implication of Elevated total cholesterol concentrations in dyslipidemic conditions and the 
progression to diseases affecting the organ systems has opened insight to attenuating recommendation that would 
reduce the TChol, LDL-C and TG and promote HDL-C distribution. An increased level of triglyceride (TG) is 
both independent and synergistic risk factor for CVD [22] and severe dyslipidemic conditions. TG/HDL-C was 
shown to be a more accurate predictor to atherogenic dyslipidemia. The logarithmatically transformed ratio of 
plasma TG/HDL-C could serve as an indicator of the atherogenic lipoprotein phenotype. The Atherogenic Index 
of Plasma (AIP) defined as log TG/HDL-C, has recently been proposed as a marker of plasma atherogenicity 
because it is increased in people at high risk for CVD and it is inversely correlated with LDL-C particles [23]. 
AIP predetermines the direction of the cholesterol transport in an intravascular pool i.e. the flux of newly 
produced cholystreyl esters by lecithin cholesterol acyl transferase (LCAT) towards atherogenic LDLs or 
beneficial HDLs [24].  
Studies also showed that AIP predicts cardiovascular risk and that it is an easily available 
cardiovascular risk marker and a useful measure of the response to treatment [25]. The quail egg yolk extract and 
cod liver oil showed atherogenic condition attenuating activities. However cod liver oil showed higher 
antiatherogenic activity compared to quail egg yolk hexane extract. Cod liver oil gave a reduced atherogenic 
coefficient and coronary risk index while no significant difference occurred between the samples with 
logarithmic atherogenic index. TG/HDL-C result showed no significant difference between the samples, while 
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the activities of the samples for HDL-C/LDL-C ratio showed a higher value for cod liver oil and lower value for 
quail egg yolk extract. Elevated HDL/LDL cholesterol ratio was associated with low risk of diseased events [18]. 
Cod liver oil has been confirmed in this research as having antidyslipidemic and hypocholesterolemic 
activities. These activities of cod liver oil are competitive with the activities quail egg yolk hexane extract. The 
frequent occurrence of atherogenic and hepatic dyslipidemic conditions have led to death of many with 
complications resulting from genetic defect (as with hypertrophic cardiomyopathy and other genetical 
atherogenic disorders with the feasibility of treatment from the perspective of dyslipidemic modulation) or diet 
(with hypercholesterolemic diet). This study is not a cognitive activity between the samples but an elaborate 
antidyslipidemic activities of the samples and thus a recommendation for quail egg yolk hexane extract as 
dyslipidemic attenuating agent.     
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